A previous study demonstrated a considerable enrichment of mutations in the JAK2/STAT3 axis in NSCLC tumors; the mutation rate was much higher in tobacco smokers than in never smokers [28]. This evidence concerns the gene JAK2 and non-small cell lung carcinoma.